SHINE Technologies is supplying UK-based Blue Earth Therapeutics with a key material for a prostate cancer clinical trial, the Janesville company says.
In a recent release, SHINE announced its partnership with the business, which develops radiopharmaceutical medicines. SHINE has provided the first supply of its lutetium-177 chloride -- or Ilumira -- product to Blue Earth Therapeutics, for use in ...
Please log in to access subscriber content.
If you don't have a subscription, click
here for a WisPolitics free trial and to view the different subscription options.
